Effectively engage with patients to help improve adherence, drive better disease understanding, and deliver treatment value.
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MOREReimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewGenerate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWElevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWOrchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWWhen your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTSBy making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MOREArtificial intelligence is accelerating opportunities. Realizing the benefits for healthcare requires the right expertise. Together, we can solve the problems of today, and drive the breakthroughs of tomorrow.
LEARN MOREThe IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MOREThe IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MOREIQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MOREIQVIA enables genomic research via global access to a network of genomic-clinical data, proprietary technologies that enable federated analytics, and therapeutic area & bioinformatics expertise to help you answer your most pressing research questions.
LEARN MOREOur mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORECareers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBSThis white paper explores evidence that improving patient engagement leads to positive outcomes for all healthcare system stakeholders. The clinical encounter is at the core of patient engagement, supporting and fostering positive health behaviors. This engagement can be amplified by patient support programs designed using the principles of behavior change, adult learning, health literacy and instructional design. Based on multimodal instructional design, such programs can enhance engagement of patients with different learning styles, using a range of modalities – print, video, digital, mobile, or face-to-face training. Behaviorally driven mobile health interventions are of particular interest, potentially offering an interactive channel to address pathways linked to sustained behavior change, although the benefits of faceto-face interaction should not be underestimated.
Effective patient engagement and empowerment – driving patients’ involvement in their own healthcare and decision making – has potential to improve treatment adherence, health outcomes and patient quality of life. However, while engagement is critical for better patient outcomes, as many as 56% of healthcare consumers in the United States show little or no engagement in their health.
Over the past decades, clinical practice has gradually been increasing its focus from an “authoritative/paternal” model to a more “collaborative/consumer” model. This shift often calls on patients as consumers to become more active in their own healthcare decisions, and to move from “adherence” to “self-management” where they have a full understanding and belief in their treatment plan. As the number of chronic disease patients is growing significantly across the world, the healthcare industry has responded to the call for increased “patient engagement,” with governments also supporting this trend.
This response aligns with a growing body of evidence demonstrating that patient-reported and quality outcomes and patient experience are improved when patients become more actively involved in their own healthcare.
The rise in patient engagement activities represents a shift in approach within the current values and outcomes era. This increase in patient engagement accompanies the changes in long-term disease prevalence and therapies, an aging population, the presence in individuals of multiple chronic medical conditions (multimorbidity), simultaneous use of multiple drugs to treat a single ailment or condition (polypharmacy), and cancer increasingly becoming a long-term condition rather than a terminal disease.
Effectively engage with patients to help improve adherence, drive better disease understanding, and deliver treatment value.
Develop a full, multi-tactic communications strategy to reach and engage patients and other stakeholders.